Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445183 · ClinicalTrials.gov registry record
COPDGene/Lung Cancer Center Database
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 250
- Enrollment target
NCT02445183: Completed study, sponsored by National Jewish Health.
NCT02445183 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445183 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The COPDGene® / Lung Cancer Database Study is a nested case-control study. This study is an ancillary study to COPDGene® Phase 1 and Phase 2. Lung cancer cases, which have been reported by COPDGene® subjects since the time of COPDGene® study enrollment, will be retrospectively verified with additional medical data collection pertaining to lung cancer. Additional 'control' subjects will also be identified and verified as a 'no lung cancer controls'. Data previously collected through the COPDGene® Study, including QCT results and clinical results (medication use, rate of acute exacerbations of COPD, etc) will be used as variables for analysis.
Primary Outcome
Use existing COPDGene® quantitative HRCT and clinical data to perform a nested case-control study and perform a univariate analysis to select significant variables for the development of lung cancer.
Interventions
- OTHER None, N/A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2013-12 |
| Est. Completion | 2020-09-22 |
What the finished NCT02445183 record still lists
NCT02445183 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which None, N/A is the first listed.
NCT02445183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445183 about?
NCT02445183 is a clinical study titled "COPDGene/Lung Cancer Center Database". The COPDGene® / Lung Cancer Database Study is a nested case-control study. This study is an ancillary study to COPDGene® Phase 1 and Phase 2. Lung cancer cases, which have been reported by COPDGene® subjects since the time of COPDGene® study enrollment, will be retrospectively verified with addition...
What is the current status of trial NCT02445183?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2013-12. Estimated completion is 2020-09-22.
What interventions are being tested in trial NCT02445183?
The interventions under investigation include: None, N/A (OTHER).
Who is sponsoring clinical trial NCT02445183?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia